Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

David Díaz‐Valle; Barbara Burgos‐Blasco; Daniela Rego‐Lorca; Virginia Puebla-García; Pilar Pérez‐García; J.M. Benítez-del-Castillo; Rocío Herrero‐Vanrell; Marta Vicario‐de‐la‐Torre; J.A. Gegúndez-Fernández

doi:10.1111/aos.14997

August 18, 2021Acta OphthalmologicaOpen Access

Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Topical insulin is an effective treatment and safely promotes healing of PED. In our series, topical insulin presented better epithelization outcomes than autologous serum and could thus be considered as a first-line treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Díaz‐Valle et al. (2021) studied this question.

synapsesocial.com/papers/69dab70400ab073a27838fec https://doi.org/10.1111/aos.14997

View Full Paper

Ask AI

Bookmark

Share

Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

Ask about this paper

Abstract

Discussion

Cite This Study

Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading